MEGAGEN IMPLANT

MegaGen Achieves Record Highs in Revenue, Operating Profit, and Net Profit

마케팅 — Mon, 22 Jun 2026 12:26:11 +0000

Operating Profit Jumps 122%, More Than Doubles from a Year Earlier Consolidated Revenue Hits KRW 545.9 Billion, Up 33% YoY

MegaGen Implant Headquarters. Photo = MegaGen MegaGen Implant Co., Ltd. (CEO Kwang-Bum Park, hereinafter “MegaGen”) achieved record-breaking results across all key financial indicators in 2025, including consolidated revenue, operating profit, and net profit. Despite ongoing uncertainties in the global business environment, such as economic slowdown and supply chain restructuring, MegaGen successfully turned challenges into opportunities through its strong technological expertise and solid management foundation. According to the company's annual report disclosed on March 31, MegaGen recorded consolidated revenue of KRW 545.9 billion in 2025, representing a 33% increase compared to the previous year. Operating profit reached KRW 69.9 billion, surging 122% year-over-year and more than doubling from the previous year. Net profit climbed to KRW 74.0 billion, increasing more than sixfold and demonstrating a remarkable improvement in profitability.

KRW 1 Trillion Revenue Target by 2030 Becoming Increasingly Attainable

A MegaGen representative stated, “These outstanding results are the product of our relentless pursuit of innovation and continuous challenges. Most notably, they mark the beginning of the ‘KRW 500 billion consolidated revenue era’ for the first time since the company’s founding.” The representative added, “As this revenue announcement serves as a clear indicator of MegaGen’s strong business fundamentals and operational capabilities, it has further strengthened our confidence in achieving our goal of KRW 1 trillion in annual revenue by 2030.” Building on this momentum, MegaGen plans to accelerate its expansion in global markets. Expectations are particularly high for the 19th MegaGen International Symposium, which will be held in Toronto, Canada, this June, where a historic collaboration project with global implant company Nobel Biocare is scheduled to be unveiled. MegaGen Implant Product Portfolio. Photo = MegaGen

Synergy Between Technology and Marketing Strengthens Global Market Leadership

A key driver behind MegaGen’s strong performance has been the powerful synergy between its brand marketing initiatives and differentiated technological capabilities. While the company has increased public awareness through a television advertising campaign featuring actor Hwang Jung-min, its flagship product, the BlueDiamond Implant, has been leading market growth. Distinguished by its blue surface created through calcium-incorporated surface treatment and its blade-like thread design, the BlueDiamond Implant is designed to shorten the osseointegration period while providing exceptional primary stability. As a result, it has earned high levels of satisfaction among both clinicians and patients. MegaGen has also reinforced its position in the global market. Last year, the company simultaneously achieved the No. 1 export ranking in both Europe and the United States, extending its record to 13 consecutive years as the leading implant exporter to Europe while also securing the top position in U.S. exports. In particular, BIOLASE, the U.S.-based company acquired by MegaGen in 2024, has completed its stabilization phase and is now entering a period of full-scale business expansion, raising expectations for even more tangible achievements this year. Meanwhile, MegaGen’s Digital Center, which began operations following an investment agreement with the Daegu Metropolitan Government last year, is emerging as a key strategic hub for the company’s future growth. Beyond simple business expansion, the facility is expected to serve as a major long-term milestone in MegaGen’s transformation into a global integrated solutions leader in the rapidly evolving digital dentistry landscape. Source: Dental Arirang(https://www.dentalarirang.com)

MegaGen Successfully Hosts Special Lecture by Dr. Paulo Malo, Creator of the All-on-4® Treatment Concept

마케팅 — Wed, 17 Jun 2026 14:45:22 +0000

Commemorating 25 Years of the All-on-4® Treatment Concept Dr. Paulo Malo Shared Long-Term Clinical Protocols and Insights into Hybrid Treatment Approaches

MegaGen Implant hosted a special lecture featuring Dr. Paulo Malo in celebration of the 25th anniversary of the All-on-4® treatment concept. Photo courtesy of MegaGen. MegaGen Implant Co., Ltd. (CEO Kwang-Bum Park, hereinafter “MegaGen”) successfully concluded a special lecture featuring Dr. Paulo Malo, the world-renowned authority in full-mouth rehabilitation and creator of the All-on-4® Treatment Concept. Held on May 10, the event attracted approximately 150 Korean clinicians interested in edentulous treatment and full-mouth rehabilitation solutions, reflecting strong enthusiasm from the dental community. As the lecture commemorated the 25th anniversary of the establishment of the All-on-4® concept, it served as a meaningful academic forum for exploring the past, present, and future of edentulous treatment.

Presenting Long-Term Strategies and Future Perspectives for Edentulous Treatment

As the keynote speaker, Dr. Paulo Malo delivered a lecture titled “CELEBRATING A QUARTER OF A CENTURY, LEADING THE WAY IN TREATING EDENTULOUS PATIENTS.” During the morning session, Dr. Malo explored the origins and core principles of the concept through presentations on “History of All-on-4®” and “What is All-on-4®.” In the afternoon, he continued with discussions on “Advantages and Disadvantages of All-on-4®” and a clinical review of the MALO BRIDGE concept. The program also covered “Surgical Procedure of All-on-4® and All-on-4® Hybrid (Zygoma)” and a series of clinical case presentations. Through these sessions, Dr. Malo shared evidence-based surgical protocols supported by long-term clinical data and introduced comprehensive treatment solutions for complex edentulous cases, capturing the audience’s attention throughout the day. During the lecture, a wide range of topics were covered, including the origins and core philosophy of the All-on-4® Treatment Concept, surgical protocols supported by long-term clinical data, and the All-on-4® Hybrid (Zygoma) approach for managing complex edentulous cases. Various clinical cases, including the MALO BRIDGE concept, were also presented, along with practical treatment strategies and guidance on long-term prognosis management, drawing significant interest from attendees. As the creator of the All-on-4® Treatment Concept and a globally recognized authority in implant dentistry, Dr. Paulo Malo emphasized the future direction of edentulous patient care and the importance of predictable treatment protocols based on 25 years of accumulated clinical experience and evidence.

Practical Maxillary All-on-6 Techniques Applicable to Korean Clinical Settings

The Special Lecture session that followed featured Dr. Kim Eun of Insaeng Plant Dental Clinic, who presented on the topic, “Any Time Immediate Loading MX. All-on-6 – Palatal Tilted Implant & Pterygoid Implant.” Dr. Kim provided an in-depth overview of the immediate loading concept utilizing six implants for maxillary edentulous patients, along with clinical application strategies for palatal tilted implants and pterygoid implants. The session received an enthusiastic response from participants, particularly for its practical insights into addressing challenging maxillary cases with limited bone volume and density—issues commonly encountered in daily clinical practice.

“Expanding Our Role as a Global Academic Platform for Full-Mouth Rehabilitation”

Clinicians who attended the event commented, “It was extremely valuable to experience the original philosophy behind All-on-4® and review long-term clinical data firsthand. We were also able to gain practical full-mouth treatment strategies tailored to the Korean clinical environment.” A MegaGen representative stated, “This lecture provided an opportunity for internationally renowned experts and Korean clinicians to share the latest knowledge and clinical perspectives in full-mouth rehabilitation, creating a highly meaningful academic exchange. We will continue to expand world-class educational programs and clinical solutions that contribute to the growth of Korean clinicians and the advancement of the full-mouth treatment market.” Building on the momentum of this event, MegaGen plans to host another special lecture this October featuring Prof. João Caramês of Portugal, the developer of the Caramês Classification system and a globally recognized authority in full-mouth rehabilitation and digital implant workflows. For seminar registration and further information, please visit MegaGen’s official website (www.megagen.co.kr) or contact the MegaGen Seminar Team at +82-2-6003-2050.

MegaGen’s ‘R2 Studio Q’ Earns MDR Certification, Strengthening Integrated Digital Diagnosis and Treatment

마케팅 — Wed, 17 Jun 2026 14:36:28 +0000

Enabling Comprehensive Diagnostics with an Integrated Imaging Platform MDR Certifications Also Obtained for MegaGen’s Intraoral Scanner and Maxillofacial Solutions

MegaGen Implant’s CBCT system, R2 Studio Q, has obtained European MDR certification. Photo courtesy of MegaGen. MegaGen Implant Co., Ltd. (CEO Kwang-Bum Park, hereinafter “MegaGen”) has further strengthened its integrated digital treatment platform by expanding European certifications across its digital dentistry portfolio. The company announced that its cone-beam computed tomography (CBCT) system, R2 Studio Q, has received certification under the European Medical Device Regulation (MDR, EU 2017/745). Having already completed MDR certification for its major product lines, MegaGen has now extended its certified digital ecosystem into the diagnostic domain with the approval of R2 Studio Q, establishing a more comprehensive integrated digital solution framework. R2 Studio Q is an all-in-one imaging diagnostic system that combines CT, panoramic, and cephalometric imaging capabilities, providing comprehensive diagnostic functionality suitable for a wide range of clinical applications. The system plays a critical role in pre-operative implant diagnosis and treatment planning. Integrated with MegaGen’s digital solutions, it enables a seamless digital workflow that connects diagnosis, treatment planning, and clinical procedures. In addition, MegaGen has recently secured MDR certification for its intraoral scanners, digital prosthetic data acquisition devices, and maxillofacial solutions. These approvals complete a certified digital workflow covering every stage of treatment, from diagnosis and data acquisition to treatment planning and clinical execution. A MegaGen representative stated, “The expansion of our MDR-certified portfolio is significant not only because it validates individual devices, but also because it demonstrates official recognition in the European market of the reliability of our integrated solutions connecting digital diagnosis and treatment.” The representative added, “We will continue to strengthen our competitiveness in the digital dentistry market by delivering technologies and product quality that meet global regulatory standards.” Meanwhile, MegaGen plans to further expand MDR certification across its digital equipment and software portfolio as part of its strategy to reinforce its position as a leading provider of integrated digital dentistry solutions in the European market. Source: Dental Arirang (https://www.dentalarirang.com)

MegaGen Hosts Paulo Malo, Creator of the All-on-4® Treatment Concept

마케팅 — Wed, 17 Jun 2026 14:14:10 +0000

Hear the ‘4-Implant Miracle’ Firsthand: MegaGen Invites Paulo Malo “25 Years of the All-on-4® Clinical Journey” to Be Held at COEX on May 10 Clinical Evidence and Prosthetic Design Insights to Be Shared, Presenting the Future of Full-Mouth Solutions

MegaGen Implant’s invited international speaker seminar, “Full Mouth Solution.” Photo courtesy of MegaGen. MegaGen Implant Co., Ltd. (CEO Kwang-Bum Park, hereinafter “MegaGen”) announced that it will host the “Full Mouth Solution” international guest speaker seminar featuring Dr. Paulo Malo of Portugal, the creator of the All-on-4® Treatment Concept, on Sunday, May 10, at the COEX Conference Room. The All-on-4® treatment concept is an innovative approach that restores both function and aesthetics by supporting a full-arch prosthesis with just four implants. The upcoming lecture is expected to revisit the “25-Year Journey of All-on-4® Clinical Practice,” backed by clinical data from more than 250,000 patients worldwide, while offering insights into the future of full-mouth rehabilitation solutions. Reflecting the strong interest from clinicians, all seats were sold out within just two weeks of registration opening.

Understanding the Essence of All-on-4® from Its Creator

Dr. Paulo Malo is a globally recognized pioneer in implant dentistry and is best known as the developer of the All-on-4® full-arch implant treatment concept. During the seminar, Dr. Malo will go beyond surgical techniques to share the scientific evidence, prosthetic design principles, and surgical expertise that have contributed to the concept’s consistently high clinical success rates over the past 25 years. Attendees are expected to gain valuable insights into managing complex cases through direct exposure to the clinical philosophy of one of the field’s most influential figures. The lecture will explore the challenges faced during the early adoption of the All-on-4® concept and trace its evolution into a widely accepted mainstream treatment modality. Key topics will include implant placement strategies, prosthetic design, and surgical techniques that underpin long-term clinical success, as well as the future of digitally driven full-arch rehabilitation. The program is designed to deliver practical, clinically focused content that participants can readily apply in their practices.

Collaboration Between International and Korean Speakers: Completing the Clinical Perspective Through the K-Session

The domestic speaker session, “K-Session,” will feature Dr. Kim Eun of Insaeng Plant Dental Clinic. Dr. Kim will present on the topic, “Anytime Immediate Loading Mx. All-on-6 – Palatal Tilted & Pterygoid Implant,” introducing clinical cases involving maxillary All-on-6 treatment. The session will provide practical full-mouth rehabilitation techniques optimized for the Korean clinical environment and offer immediately applicable solutions for everyday practice.

MegaGen: “Setting a New Standard for Full-Mouth Treatment”

A MegaGen representative commented, “The early sell-out of this seminar demonstrates the strong demand among Korean clinicians for more advanced full-mouth treatment solutions. By combining Dr. Paulo Malo’s 25 years of expertise with MegaGen’s cutting-edge digital technologies, this event will help lead new trends in the domestic full-mouth rehabilitation market and provide clinicians with a clear direction for the future.” MegaGen also stated that it plans to continue promoting the advancement and wider adoption of full-mouth solutions in Korea through collaborations with globally renowned experts and educational programs. In October of this year, MegaGen is scheduled to host another special lecture featuring Prof. João Caramês of Portugal, the developer of the Caramês Classification system and a world-renowned authority in full-mouth rehabilitation and digital workflows. For seminar registration and additional information, please visit MegaGen’s official website (www.megagen.co.kr) or contact the Seminar Team at +82-2-6003-2050. Source: Dental Arirang (https://www.dentalarirang.com)

OSTEOLOGY 2026

마케팅 — Mon, 11 May 2026 09:35:56 +0000

Megagen Achieves “Six Certifications” Under EU CE MDR… Builds a Complete Dental Solution Portfolio

마케팅 — Fri, 08 May 2026 09:34:50 +0000

Certification of implants and dental chairs since 2022 Record of No. 1 exports to Europe for 13 years and to the United States for 5 years

Megagen Implant Co., Ltd. (CEO Kwang-Beom Park, hereafter “Megagen”) has achieved Korea’s first “six-category certification” by securing EU CE MDR certification across the entire dental treatment solution spectrum, including implants, kits, and dental unit chairs. This achievement is particularly noteworthy as it includes certification of the dental unit chair N2, completing a fully integrated “dental solution” that spans implant fixtures, prosthetics, surgical kits, and treatment environments. Megagen’s proactive and comprehensive MDR certification strategy across all product areas has been steadily built since the first certification of the XPEED AnyRidge Internal System in 2022, and is widely regarded in the industry as a uniquely distinguished accomplishment. To date, Megagen has obtained MDR (EU Regulation 2017/745) certification for a total of six product groups: △XPEED AnyRidge Internal System △AnyOne Internal System △Anterior solution ARi △Posterior difficult-case solution BD Cuff △Full-mouth specialized AXA Abutment △Dental unit chair N2 Chair (all types). CE MDR is a stringent European regulation that replaced the former Medical Device Directive (MDD), requiring robust clinical evidence, risk management, and post-market surveillance. Megagen has systematically responded since the early stages of MDR implementation by restructuring its clinical evaluation system, refining technical documentation, and enhancing PMS (Post-Market Surveillance) and PMCF (Post-Market Clinical Follow-up), thereby steadily expanding its certification portfolio. A Megagen representative stated, “This achievement signifies that our global-standard quality system has been extended across the entire clinical workflow,” adding, “We will continue to strengthen our competitiveness through a regulatory-first development strategy and accelerate our global market expansion.” Megagen currently exports to over 100 countries, including Europe, the United States, and CIS regions, recording 13 consecutive years as the No. 1 exporter in Europe and 5 years as the No. 1 exporter in the United States. With this achievement, the company is expected to further solidify its position as a leading representative of K-implant technology. For more information, please visit the official website (www.megagen.co.kr) or contact the customer service center at +82-1566-2338. Source: Dental Arirang (https://www.dentalarirang.com)

‘Hwang Jung-min’s Blue Implant’ Megagen Earns Global Quality Certification for 10 Consecutive Years

마케팅 — Fri, 08 May 2026 09:28:26 +0000

Familiar from actor Hwang Jung-min’s advertisement featuring the “blue implant,” Megagen Implant has once again proven its world-class quality, earning strong trust from consumers. Megagen announced on the 25th that it has obtained the “TRUSTED QUALITY” certification this year from Germany’s Clean Implant Foundation, a global implant quality certification body. This achievement marks a “10 consecutive years certification” streak since first obtaining it in 2017 as the first company in Korea, a rare record even on a global scale.

◆ Microscopic-Level Strict Inspection

The Clean Implant certification involves randomly collecting implant samples from around the world and conducting highly precise microscopic-level analysis to detect any microscopic residues or contaminants on the surface. The standards are extremely strict, making it difficult even to maintain certification. Megagen’s achievement of sustaining this certification for 10 consecutive years reflects its commitment to perfect control over everything from raw materials to manufacturing processes, guided by the principle of “as if placing it in my own family member’s mouth.”

◆ Unique “Blue” Technology

The reason Megagen implants appear blue is due to its patented XPEED surface treatment technology. This technology bonds calcium to the implant surface to help bone integrate faster and more strongly within the body, while completely removing any residual acidic substances from the manufacturing process. This reduces inflammation risk and creates a stable healing environment. This innovation is also applied to the premium “BlueDiamond Implant,” currently featured in advertisements, and is widely regarded by dentists as a “reliable product” and by patients as a “safe and reassuring choice.”

◆ Pride of K-Implant

Megagen’s quality has already been recognized in overseas markets. It has recorded 13 consecutive years as the No. 1 exporter in Europe and 5 cumulative years as the No. 1 exporter in the U.S. (based on Korea International Trade Association statistics), meeting the high standards of patients in advanced markets. Since its founding in 2002, the company has expanded exports to more than 100 countries, elevating the global status of Korean implant technology. A Megagen representative said, “The 10-year consecutive quality certification is the result of keeping our promise to provide the cleanest and safest implants to our customers,” adding, “We will continue to go beyond global standards through strict quality management and become a leading company responsible for the nation’s oral health.” More details can be found on Megagen’s official website or through phone inquiries. Source: THE Biz (http://www.the-biz.co.kr)

Megagen Implant Achieves No. 1 in Exports to Europe for 13 Consecutive Years

마케팅 — Fri, 08 May 2026 09:18:14 +0000

“Recognized in the Global Market for Its Unrivaled Technological Competitiveness”

Megagen Implant (CEO Kwang-Beom Park, hereafter “Megagen”) achieved No. 1 export rankings in both Europe and the United States last year, setting a new record with 13 consecutive years as the top exporter to Europe, along with the No. 1 position in exports to the U.S.

Based on export records from the Korea International Trade Association Statistics Promotion Institute, this achievement demonstrates that Megagen’s technological expertise and product quality continue to earn recognition across global markets, including Europe and the United States. Megagen stated, “By maintaining stable and continuous growth in export performance, we have reaffirmed our position as a leading company at the center of the global dental industry.”

At the core of Megagen’s competitiveness is its differentiated innovative technology. Its flagship patented XPEED surface treatment technology combines calcium—an essential element for bone regeneration—with the implant fixture surface while removing residual acidic substances that may remain after surface treatment. This enables faster osseointegration and provides a more stable healing environment. The blue-colored implant surface created through this technology has become a symbol of Megagen’s technological excellence.

Based on these technologies, Megagen has also become the only Korean company to receive the “TRUSTED QUALITY” certification from Germany’s Clean Implant Foundation for 10 consecutive years, proving its reliability under global quality standards.

In addition, its proprietary Knife Thread design, featuring a blade-like structure, minimizes bone damage while ensuring firm placement and excellent primary stability. This allows for stable implant placement and reduced treatment periods across a wide range of clinical environments.

Beyond technological development, Megagen continues to contribute to the advancement of dentistry through global clinical education and academic activities. Centered around MINEC, its global clinical education institution, the company shares the latest clinical knowledge with dentists worldwide while conducting educational and research programs in various countries and regularly hosting international symposiums.

In particular, through the MEGA’MIND program, Megagen is discovering and nurturing the next generation of leaders in implant education, focusing on developing talent that will shape the future of global implant education. Beginning this year, the introduction of a real-time AI translation system has attracted significant industry attention by enabling anyone to learn the latest clinical trends without language barriers.

Meanwhile, Megagen is expanding public brand awareness through a TV advertising campaign launched in 2025 featuring actor Hwang Jung-min as its model, emphasizing the “blue innovation” of its implant technology as a key brand identity for consumers.

A company representative stated, “Megagen, which continues to write the history of implant technology through world-first innovations, is solidifying its global standing with its No. 1 export rankings in Europe and the United States while creating a new future for K-implant technology.”

Megagen Announces 21 Finalists for MEGA’MIND 2026, Its Global Speaker Discovery Program

마케팅 — Fri, 08 May 2026 09:07:56 +0000

Over 400 Participants from More Than 60 Countries Worldwide... Real-Time AI Translation Receives Positive Reviews Three Koreans Advance to the Finals... Military Doctor Seongjin Kim, Director Jeongju Kim, and Assistant Professor Yerim Oh Confirmed as Finalists

Three Korean Finalists Advancing to the MEGA’MIND 2026 Continental Rounds Final. From left: Director Jeongju Kim (Meister Dental Clinic), Assistant Professor Yerim Oh (Dankook University Jukjeon Dental Hospital), and Military Doctor Seongjin Kim (Medical Battalion, 12th Infantry Division of the Republic of Korea Army). Photo = Megagen MEGAGEN IMPLANT Co., Ltd. (CEO Kwang-Beom Park, hereafter “Megagen”) has concluded the seven continental rounds of its next-generation global speaker discovery project, “MEGA’MIND 2026,” finalizing a total of 21 finalists. With more than 400 participants from over 60 countries, this year’s competition has established itself as one of the largest international contest programs in the field of dentistry and a premier stage for discovering future leaders in global implant education. Now in its fourth year, MEGA’MIND goes beyond a simple presentation contest by comprehensively evaluating clinical excellence, the reliability of research data, the systematic analysis of cases, and presentation delivery skills. Following preliminary rounds held from May to November last year, selected participants competed fiercely in the continental rounds beginning in February. Ultimately, the top three participants from each continent—21 finalists in total—earned spots on the final stage in Toronto this June. This season was also significant for becoming the first dental competition to introduce a real-time AI translation system, lowering barriers to global academic exchange. The continental rounds were livestreamed worldwide through the official website, and presentations were translated in real time so audiences everywhere could easily follow the content. Viewers were able to select their preferred language, creating an environment where clinical cases and treatment strategies could be shared without language barriers between countries. Industry observers praised the initiative, saying it “set a new standard for international academic platforms.” Among this year’s competition stages, the Korean round stood out the most. Korea has consistently been recognized as one of the most competitive regions in the competition, known for its high level of clinical sophistication and logically structured presentations. In particular, this year’s Korean round was hosted by Military Doctor Chanyoung Park, winner of MEGA’MIND 2024. Participants captured the attention of the judging panel by presenting a series of highly complex cases, including full-mouth rehabilitation procedures. They received especially high praise not only for introducing treatment techniques, but also for systematically presenting long-term prognosis data and detailed treatment protocols.

The 21 finalists confirmed for MEGA’MIND 2026. Photo = MegagenThe judging panel included Director Hyunsik Park (Heim Dental Clinic, Prosthodontics), Professor Hobum Kwon (Department of Prosthodontics, Seoul National University Dental Hospital), Professor Byungeun Yang (Department of Oral and Maxillofacial Surgery, Hallym University Sacred Heart Hospital), and Professor Joongseok Lee (Department of Periodontics, Yonsei University Dental Hospital). Fair evaluations were conducted across 10 criteria, including clinical excellence, document organization, the completeness of research and data, and presentation attitude. After intense competition, the three finalists selected from Korea were Military Doctor Seongjin Kim (Medical Battalion, 12th Infantry Division of the Republic of Korea Army), Director Jeongju Kim (Meister Dental Clinic), and Assistant Professor Yerim Oh (Dankook University Jukjeon Dental Hospital). They were recognized for elevating the overall quality of the competition stage through more sophisticated case analyses and data-driven presentations compared to last year. The finalists stated, “We will prepare even more thoroughly for the final round and clearly demonstrate the strength of Korean clinicians on the global stage.” The final round will take place on June 19 in Toronto alongside the Megagen Implant International Symposium. Continental round winners will receive round-trip airfare to Toronto, accommodation, and symposium registration benefits. The final stage will also be broadcast worldwide through real-time AI translation and global live streaming. A Megagen representative stated, “MEGA’MIND is not simply a competition, but a platform where dentists around the world can share clinical experiences and grow together,” adding, “Through the final stage in Toronto, we aim to discover the next generation of speakers who will perform on the global stage and create an international competition platform that showcases clinical practices from Korea and other regions worldwide.” The MEGA’MIND live broadcasts can be viewed through the official MEGA’MIND website (www.globalmegamind.com), and anyone can watch in real time. For inquiries, contact inquiry@globalmegamind.com or call +82-1566-2338. Source: Dental Arirang (https://www.dentalarirang.com)

[Hot Product] MegaGen Implant ‘Accelerated Loading Concept’

마케팅 — Thu, 07 May 2026 17:00:27 +0000

“Implant loading paradigm: from waiting to certainty” Accessible in any situation—regardless of bone quality or ridge condition

In implant dentistry, the use of immediate and early loading protocols is increasingly expanding as a means to reduce treatment time and improve patient satisfaction. However, challenges such as achieving sufficient primary stability, variability in predictability depending on bone quality, and the temporary decrease in stability that typically occurs around three weeks after placement (the so-called “stability dip”) continue to make clinicians cautious about early loading. MegaGen Implant (CEO Kwangbom Park, hereinafter MegaGen) proposes a paradigm shift through its “Accelerated Loading Concept,” designed to overcome these limitations.

“Filling the gap of stability”

The Accelerated Loading Concept is not simply about advancing the timing of loading, but rather about achieving faster, more precise, and more predictable clinical outcomes by enhancing initial mechanical stability and accelerating biological stability. Implant stability can be divided into mechanical stability at the time of placement and biological stability during the osseointegration process. Typically, mechanical stability is high immediately after placement but gradually decreases over time, while biological stability progressively increases as osseointegration occurs. The period around three weeks after placement—when these two forms of stability intersect—is known as the “stability dip,” during which overall stability temporarily declines. This has long been one of the major obstacles to early loading. MegaGen’s Accelerated Loading approach minimizes this transition gap by combining strong initial fixation with accelerated bone formation. Through this strategy, the company states that it enables stable osseointegration and predictable treatment outcomes under a wide range of clinical conditions.

A strategy that goes beyond the limitations of bone quality

In general bone conditions (D1–D3), the key to the Accelerated Loading Concept lies in achieving high initial stability and rapid osseointegration. According to MegaGen, this concept has demonstrated in key human studies that even in D4 bone quality, insertion torque (ITV) was maintained above 40 Ncm. In addition, 39 out of 40 implants recorded ISQ values above 70, indicating a stability range suitable for early loading. Notably, these cases showed no typical temporary dip in ISQ values, maintaining consistently stable readings throughout. The company attributes these outcomes to core technologies applied in the AnyRidge and BLUEDIAMOND implant systems. First, the XPEED Surface technology is based on a calcium titanate nano-structured surface that enhances protein and cell adhesion while promoting osteoblast activity, thereby accelerating bone formation. Compared to conventional SLA surfaces, it achieves higher bone-to-implant contact (BIC), supporting faster and more reliable osseointegration. In addition, the specialized Knife Thread design reduces compressive stress during insertion, minimizing bone trauma and preserving bone architecture. It also increases surface area to achieve higher BIC, while the thread spacing is designed to be up to four times wider than conventional systems, allowing improved blood supply and faster bone healing. Attention is also drawn to the design philosophy that separates the implant core and thread as independent elements. The optimal core diameter is selected based on occlusal load requirements, while thread depth can be adjusted flexibly according to bone quality. In particular, the high-strength BLUEDIAMOND implant utilizes this technology to secure both superior mechanical strength and primary stability even in limited clinical conditions, enabling the realization of Accelerated Loading protocols.

A strategy that goes beyond the limitations of GBR

Alveolar bone resorption, resulting in ridge deficiency, is one of the main factors that complicates implant placement. As a solution, MegaGen proposes the “ARi Solution,” which utilizes the concept of engaging the non-resorbing basal bone. Since basal bone remains stable over time, it allows for reliable implant placement regardless of the condition of the resorbed alveolar ridge. For this purpose, a cuff design is applied in the coronal portion to minimize the risk of peri-implantitis even if the thin residual bone resorbs and becomes exposed. In the apical portion, a roughened surface is applied to ensure stable osseointegration with the basal bone. Instead of relying on GBR in the cuff region, contourization is performed to preserve soft tissue volume. In addition, the BD Cuff is designed to maintain stability even in dehiscence situations, effectively addressing clinical challenges such as narrow posterior ridges or defect ridges. Based on Professor Tomas Linkevicius’s “Zero Bone Loss” concept, it features a machined cuff of more than 2 mm, forming a soft tissue zone exceeding 4 mm to suppress crestal bone loss around the implant neck. This allows clinicians to use implants with appropriate functional diameters without relying on narrow implants or GBR, while establishing a stable soft tissue environment. A MegaGen representative stated, “While implant dentistry in the past relied on waiting as a routine approach, MegaGen’s Accelerated Loading Concept is based on technological certainty,” adding that “for clinicians who have hesitated to load implants in poor bone quality or deficient ridges, MegaGen provides the simplest, fastest, and safest pathway. It offers patients a faster return to daily life and gives clinicians an efficient treatment system and confidence in prognosis. Accelerated Loading will represent a new peak in implant treatment.”

[Hot Product] MegaGen Implant ‘Full Mouth Solution’

마케팅 — Thu, 07 May 2026 16:45:44 +0000

“Full mouth, made easy for everyone, completed within 8 weeks” Declaration of the popularization of the All-On-X procedure

MegaGen Implant (CEO Kwangbom Park, hereinafter MegaGen) has combined its digital diagnostic capabilities with its distinctive implant design to overcome the limitations of the domestic market, presenting a “Full Mouth Solution” that is intuitively accessible to everyone. According to MegaGen, applying this solution enables rapid post-surgical recovery of patient function and significantly accelerates the overall treatment process.

MegaGen steps in to address concerns over full-mouth restoration

In South Korea, implant dentistry has traditionally shown a strong preference for preserving individual teeth and placing implants in partial restorations rather than full-mouth rehabilitation. This is widely attributed to patients’ strong desire to retain natural teeth, as well as the psychological and physical burden associated with extensive bone augmentation procedures (GBR) required for full-mouth rehabilitation, along with longer treatment periods and higher costs. However, with the recent acceleration of population aging and a sharp increase in edentulous patients, there is a growing emphasis on “rapid restoration of masticatory function” as a key determinant of quality of life. As a result, demand for full-mouth implant solutions continues to rise. The core of MegaGen’s Full Mouth Solution lies in the principle that implant positioning is not simply based on the existing bone (“bone-centered”), but is instead determined according to the final prosthetic outcome. In conventional approaches, implants were placed according to the shape of the remaining bone, which often led to a mismatch between the prosthesis and implant axis, or resulted in complications such as fractures or peri-implantitis due to biomechanical overload. In contrast, MegaGen first designs the position and morphology of the final prosthesis, and then determines implant positioning and angulation without being constrained by residual bone conditions. Through its specialized implant system that enables even distribution, the company states it can ideally disperse masticatory forces and secure long-term stability.

Completion of the digital workflow

The MegaGen Full Mouth Solution achieves an even higher level of completeness when combined with a digital workflow. One of the most challenging aspects in treating edentulous patients is establishing vertical dimension (VD) and performing the diagnostic process. Traditionally, these steps relied on bite rims and manual procedures, which had limitations in terms of accuracy and reproducibility. However, the QVD system and Dental Avatar-based platform from R2studioQ integrate CBCT, facial scans, and intraoral scan data to generate a three-dimensional virtual patient. Key parameters such as the midline, smile line, occlusal plane, and vertical dimension are automatically analyzed using AI technology, allowing optimal diagnostic values to be established. The determined vertical dimension, along with occlusal records and wax-ups, can then be exported as STL files for the fabrication of surgical guides and the design of provisional teeth. Even in cases where implants are placed first, vertical dimension calculation and provisional restoration design remain possible, enabling the fabrication of temporary prostheses within three hours after surgery and the rapid restoration of both esthetics and function for the patient.

The more complex the edentulous case, the simpler the approach should be.

MegaGen’s BlueDiamond, ARi, and BD Cuff systems serve as core solutions for realizing the “ideal implant position” for edentulous prosthetic rehabilitation without additional bone grafting. Rather than artificially modifying bone conditions, these systems adopt a strategy that maximizes the use of the existing bone structure. In full-mouth implant cases, BlueDiamond’s high strength—approximately twice that of competing implants of the same diameter—allows it to withstand high occlusal loads even in narrow ridges with advanced alveolar bone resorption. By minimizing prosthetic stress, it enables placement in reduced bone width without the need for bone augmentation procedures. In addition, BlueDiamond’s Core & Thread structure and Knife Thread design provide high primary stability, reduce the risk of implant fracture due to superior mechanical strength, and enhance treatment speed and long-term stability through rapid osseointegration enabled by the calcium-enhanced XPEED surface technology. ARi and BD Cuff are particularly useful in challenging clinical situations such as thin ridges and bone defects. Their strategy of anchoring in non-resorbed basal bone is supported by the unique Magic Cuff design and structural advantages of ARi and BD Cuff, enabling simpler surgical procedures even in cases that traditionally required bone grafting.

Improved prosthetic stability and enhanced long-term prognosis

Conventional Multi-Unit Abutments (MUAs) have been effective in All-on-X prosthetic cases; however, their limited contact surface and small-diameter screws have been associated with long-term risks such as screw loosening and fracture. MegaGen’s AXA Abutment system addresses these structural limitations at their core. Its wider contact surface and reinforced connection structure distribute occlusal forces more evenly, improving tightening stability and ensuring long-term prosthetic reliability. In addition, by directly connecting the crown and abutment with a screw-retained structure, it enables a true cementless prosthesis. This helps eliminate risks associated with residual cement, such as inflammation and peri-implantitis. MegaGen’s Full Mouth Solution is centered on simplifying the surgical process to lower barriers to entry and leveraging digital technology to achieve exceptional speed. It transforms full-mouth implant treatment—traditionally performed by highly experienced clinicians under long-term planning—into a more standardized and accessible procedure. According to MegaGen, even complex edentulous cases can be completed through to final prosthesis delivery within as little as eight weeks. As a result, the Full Mouth Solution is said to bring significant improvements to both clinical practice and dental clinic operations, including dramatically reduced chair time, standardized procedures, and improved treatment predictability, which in turn enhances patient consultation clarity and acceptance rates. A MegaGen representative stated, “The MegaGen Full Mouth Solution promises clinical confidence for clinicians and quality-of-life restoration for patients,” adding, “We invite clinicians to directly experience MegaGen’s differentiated innovation and seize new opportunities for growth.”

MegaGen Implant Co., Ltd. is scheduled to hold an international symposium in Toronto, Canada

마케팅 — Thu, 07 May 2026 16:32:37 +0000

In collaboration with Nobel Biocare… a 50-year legacy of implant dentistry.

MegaGen Implant Co., Ltd. (CEO KwangBum Park, hereinafter “MegaGen”) will hold the 19th MegaGen International Symposium in Toronto, Canada on June 20 and 21. This symposium is drawing attention from the academic community as it will take place in Toronto, a historic site where the framework of modern implant dentistry was established. In particular, through collaboration with Nobel Biocare, often referred to as a pioneer in implant dentistry, the event is expected to summarize the clinical legacy of the past 50 years and present a blueprint for the next 50 years led by artificial intelligence (AI) and digital technologies. In 1982, the first Toronto Conference was held in Toronto, Canada. Through this conference, the concept of osseointegration was officially introduced to North American academia, becoming a decisive turning point that established modern implantology as a mainstream field in dentistry. This is the reason MegaGen selected Toronto as the venue for this symposium. A MegaGen representative stated, “By looking back at the beginning of modern implant history and discussing next-generation innovative technologies, we aim to emphasize the continuity of dentistry.” The MegaGen Symposium, under the slogan “Reviewing the Past 50 Years, Envisioning the Next 50 in Implant Dentistry,” will comprehensively present implant surgical and prosthetic protocols accumulated over the past half-century. In particular, it will focus on digital workflows and AI-based diagnostic and treatment solutions, which are currently among the most prominent topics in clinical practice. A key emphasis will be MegaGen’s “evidence-based protocol,” which highlights technologies that can be immediately applied in clinical settings. The program will cover the entire process—from AI-based precise diagnosis to guided surgery and digital prosthesis fabrication. Through this, it is expected to present concrete approaches to improving treatment accuracy and maximizing clinical efficiency. Nobel Biocare will participate in this MegaGen Symposium. Through this collaboration, MegaGen aims to show respect for the traditional technologies that form the foundation of implant dentistry, while further strengthening its global market position by combining them with its innovative digital technologies. The lecture program will feature leading figures in modern dentistry. These include George Zarb, Professor Emeritus at the University of Toronto, who helped establish the Brånemark system in North America; Tomas Albrektsson, Professor Emeritus at the University of Gothenburg, who established the “Albrektsson criteria,” a benchmark for implant success; and Dennis Tarnow of Columbia University, widely known for the “5 mm rule” in implant esthetic treatment. Other speakers include Clark Stanford, Dean of the University of Iowa College of Dentistry; Paulo Malo, founder of the All-on-4 concept; and Francesco Mangano, President of the Italian Society of Digital Dentistry. Korean speakers will include MegaGen CEO KwangBum Park, Professor Kyu-Jin Cho of Seoul National University School of Dentistry, and Professor David Kim of Harvard School of Dental Medicine. MegaGen aims to present new standards and innovative solutions that go beyond existing paradigms in dentistry, thereby strengthening its leadership in the global market. A MegaGen representative stated, “This Toronto symposium is a symbolic event where the historical birthplace of implant dentistry meets the site of future innovation. By sharing new treatment standards with world-renowned scholars, we aim to lead meaningful change in the global dental community.”

MegaGen Implant and BIOLASE Unite to Shape the Future of Dental Innovation

마케팅 — Mon, 09 Feb 2026 12:17:20 +0000

MegaGen Implant and BIOLASE have officially joined forces, marking a significant step forward in advancing comprehensive dental treatment solutions worldwide. This strategic integration brings together MegaGen’s global leadership in implantology with BIOLASE’s pioneering expertise in dental laser technology, creating powerful synergy across clinical innovation, education, and customer support. With BIOLASE now part of the MegaGen family, dental professionals can expect enhanced collaboration between two technology-driven organizations committed to improving treatment outcomes and patient experiences. BIOLASE has long been recognized as a global innovator in dental laser systems, with technologies such as Waterlase®, diode laser platforms, and Epic laser systems transforming minimally invasive dentistry. Through its integration with MegaGen, BIOLASE is positioned to further expand its clinical applications while strengthening service capabilities and global training programs. MegaGen Implant, founded by clinicians for clinicians, has built a strong global presence through its advanced implant systems, digital dentistry solutions, and education-driven approach. By incorporating BIOLASE’s laser technology portfolio, MegaGen aims to provide more comprehensive treatment solutions that support clinicians across a broader range of procedures, including soft tissue management, infection control, and regenerative therapy. Dr. Kwang Bum Park, Founder of MegaGen Implant and CEO of BIOLASE, emphasized the shared vision behind the integration. “MegaGen and BIOLASE share a common philosophy centered on innovation, clinical excellence, and dedication to dental professionals worldwide. By combining our strengths, we are creating new opportunities to expand advanced treatment solutions and deliver greater value to clinicians and patients.” The integration is expected to accelerate research and development, strengthen global education programs, and enhance customer service infrastructure. MegaGen plans to support BIOLASE’s continued growth through expanded training initiatives and deeper collaboration with clinicians worldwide. This union represents more than the combination of two companies—it reflects a shared commitment to shaping the future of dentistry through innovation, technology, and education. As MegaGen and BIOLASE move forward together, the partnership is expected to drive new advancements in minimally invasive dentistry while reinforcing both brands’ dedication to improving clinical outcomes and elevating the global standard of patient care.

19th MegaGen International Symposium in Toronto

마케팅 — Wed, 24 Dec 2025 10:53:11 +0000

A New Game Changer in Anterior Atrophic Ridge, ARi

마케팅 — Thu, 23 Oct 2025 18:03:19 +0000

Acquires strong stability and osseointegration, even in the limited alveolar bone

MegaGen Implant Co., Ltd. (CEO KwangBum Park, hereinafter ‘MegaGen’) has announced the launch of its groundbreaking new implant, ARi, which has attracted significant attention in the dental implant industry. Unlike conventional implants, ARi secures strong primary stability and osseointegration by anchoring into the unresorbed basal bone rather than the atrophied alveolar bone.

Ensuring strong primary stability from the basal bone

ARi®(AnyRidge Incisor) secures strong primary stability and osseointegration from the unresorbed basal bone, helping to prevent a range of complications that often arise in patients with resorbed alveolar bone, where implant placement is can be especially challenging. With ARi, MegaGen introduces a new solution that ensures long-term stability even in cases of alveolar bone loss through its innovative implant body design. MegaGen stated, “The ARi® implant system offers a new solution for anthropic anterior cases through a simplified surgical protocol without the need for bone grafting. Since its launch, inquiries about the new product have been pouring in.” MegaGen has applied its proven KnifeThread® design to the lower part of the ARi fixture, ensuring strong primary stability from the basal bone. This design enables ARi to achieve higher ISQ values immediately upon placement. The threaded section anchored in the basal bone delivers enhanced stability and stronger osseointegration, so implant stability is not compromised even in cases with insufficient alveolar bone volume. As a result, ARi supports immediate placement as well as immediate or early loading. In addition, ARi maintains implant stability by positioning its rough surface deep within the basal bone, even if alveolar bone loss occurs after implant placement. This design significantly reduces the risk of exposure to oral bacteria. MegaGen emphasized, “Patients can undergo faster and more comfortable surgery and recovery without spending extensive time on alveolar bone volume restoration. ARi also enables higher levels of anterior masticatory function compared to traditional long-bridge solutions. In particular, it reduces the need for reoperations due to complications that may arise long after implant placement, setting it apart from conventional anterior implants.”

Ensuring long-term stability even in cases of bone loss

The ARi® implant is designed to maintain stability even in cases of resorbed alveolar bone. Its design allows for optimal stress distribution, providing higher strength relative to its diameter and reducing the risk of fracture. In addition, it facilitates easier management of peri-implantitis and other complications, minimizing postoperative risks. The ARi® implant not only helps prevent bacterial colonization and subsequent complications, such as peri-implantitis and fractures after restoration, but also allows for easy removal if such issues occur. Its unique cuff design promotes the formation and proliferation of HGF-cell (Human Gingival Fibroblasts), supporting rapid soft-tissue regeneration and preventing tissue recession. The ARi® implant features MegaGen’s patented surface treatment technology, XPEED®, on both the lower part of the fixture and the cuff area. Ca2+ ions are deposited onto the implant surface, creating a nanostructure. This process effectively eliminates any residual acids that may remain during implant manufacturing through calcium-ion incorporation. Unlike other implants, XPEED®-treated surfaces can be visually identified by their distinctive blue color, which serves as a safety indicators.

Excon connection for strong joint stability

The ARi® implant features a 10° external conical hex connection, providing strong joint stability between the implant and abutment. During mastication, this design distributes stress, ensuring maximum strength relative to its diameter. MegaGen explains that this represents over a 200% increase in strength compared to its narrow zone implant system. Meanwhile, MegaGen has officially launched ARi® at SIDEX 2023, garnering significant attention.

BD Cuff: A Special Solution for Thin Mandibular Ridges without Thread Exposure

마케팅 — Thu, 23 Oct 2025 17:59:54 +0000

Comfortable Implant Placement Even in Severe Defects…

Dramatically Reducing Chair Time

MegaGen Implant Co., Ltd. (CEO KwangBum Park, hereinafter ‘MegaGen’) is receiving high praise from users for its BD Cuff™ Implant (hereinafeter “BD Cuff™”), which provides a simple solution for challenging mandibular thin ridges and bone defects. MegaGen stated, “Within just three weeks of the pre-launch, more than 300 dental clinics in Korea began using BD Cuff™, and following its official launch at SIDEX 2024, it has continued to generate overwhelming interest and strong contract results. BD Cuff™ offers a new experience for dental professionals as a molar-focused simple solution, enabling comfortable surgery without concerns about thin posterior ridges or thread exposure, and allowing treatment of severe buccal and lingual defects without the need for GBR, which has led to a surge of inquiries.”

Collaboration of BLUEDIAMOND implant strength & ARi implant concept!

The BD Cuff™ combines the strength of BlueDiamond implant with the concept of ARi® (AnyRidge Incisor). Leveraging the proven stability of the BlueDiamond X-Fit™ connection, it ensures precise and secure attachment through a double-fastened connection: once with an arch-shaped keystone on a 30° internal conical connection, and twice with an octa connection. In addition, the machined magic cuff design, inherited from ARi, helps prevent complications such as peri-implantitis due to bone loss, while allowing easy removal if such issues occur. The BD Cuff™ can be placed even in thin, low or defective alveolar ridges without the need for GBR, significantly reducing the overall treatment time to final prosthesis. In contrast, with other conventional implants, when bone defects occur, GBR is typically required to prevent thread exposure, followed by a healing period of 5-6 months before a successful bone graft can be achieved. With BD Cuff™, however, this additional process is unnecessary. The machined cuff of the BD Cuff™ is positioned in the soft tissue area, preventing thread contamination or minimizing the potential risk of peri-implantitis. In addition, the machined magic cuff of the BD Cuff™ is designed with a minimum height of 2mm. This ensures the formation of more than 4mm of soft tissue even in posterior regions with thin gingiva thickness (<2mm), allowing bone loss to be minimized with a simple epicrestal placement. It also eliminates the need for subcrestal placement or soft tissue augmentation, which are often required to prevet complications from bone loss. Notably, the BD Cuff™ enables final prosthesis placement as early as one month after one-stage surgery. This not only shortens patients’ chair time but also reduces clinical fatigue, delivering higher satisfaction to both patients and clinicians.

Prevention of peri-implantitis

Furthermore, the BD Cuff™ is distinguished by its mechanical stability, featuring up to 200% greater strength compared to conventional implants, and a machined magic cuff that ensures long-term durability. While the BlueDiamond Implant was launched with the slogan “Stronger than the Strongest,” the BD Cuff™ shares the same design concept, alleviating stress from implant fractures thanks to its high compressive and fatigue strength. By positioning the roughened surface deep within the bone, the BD Cuff™ ensures strong primary stability, while its machined magic cuff greatly minimizes exposure to oral bacteria. Consequently, even if peri-implantitis or other complications arise from alveolar bone loss after placement, the implant maintains long-term stability, unaffected by the bone loss. To ensure strong primary stability, the BD Cuff™ incorporates MegaGen’s proven KnifeThread® design on the lower section of the fixture, enabling higher ISQ values immediately upon placement. The threaded section anchored in the basal bone provides stable and strong osseointegration, so that even insufficient alveolar bone volume does not compromise stability, allowing for immediate placement as well as immediate or early loading. In addition, the BD Cuff™ features MegaGen’s patented surface treatment technology, XPEED®, on both the lower part of the fixture and the cuff area. Ca2+ ions are deposited onto the implant surface, creating a nanostructure. This process effectively eliminates any residual acids that may remain during implant manufacturing through calcium-ion incorporation. Unlike other implants, XPEED®-treated surfaces can be visually identified by their distinctive blue color, which serves as a safety indicators. MegaGen stated “This blue surface serves as a safety indicator, and its calcium-incorporated nanostructure promote faster bone formation.” XPEED® undergoes a hydrothermal process that incorporates Ca2+ ions onto the fixture surface, forming a CaTiO3 structure. This nanostructure promotes bone-forming cells and activates osteoblasts, resulting in a bone matrix layer on the fixture surface. The enhanced reactivity of the implant surface also creates a favorable environment for protein adsorption and bone cell adhesion. MegaGen stated, “Thanks to this surface treatment technology, XPEED® is recognized as one of the most advanced implant surfaces currently available.”

BlueDiamond: Stronger Implants, Relieving Stress on Fixture Fracture

마케팅 — Thu, 23 Oct 2025 17:56:59 +0000

Demonstrating MegaGen’s Precision, Minimizing the Need for GBR

MegaGen Implant Co., Ltd. (CEO KwangBum Park, hereinafter ‘MegaGen’) has drawn attention from dental professionals with the launch of the BlueDiamond Implant, which is stronger than conventional implants. MegaGen stated that the BlueDiamond was developed to provide a long-term solution for mechanical and biological implant complications, particularly fractures, that can arise as a result of the expanded implant base.

Stronger than the Strongest

MegaGen stated, “BlueDiamond Implant combines the highest strength in the global implant market with long-term biological stability. It delivers excellent initial stability upon placement in any bone condition, features a design optimized for minimally invasive treatment, and applies the patented XPEED surface treatment, which is superior to the conventional S-L-A surface. In addition, BlueDiamond has demonstrated long-term prevention of peri-implant tissue recession, and its precise prosthetic design minimizes misfitting and screw loosening – all of which have fueled a strong market response even at the early stage of its launch in Korea. BlueDiamond Implant, introduced under the slogan of “Stronger than the Strongest,” stays true to its foundation by using Medical Grade 4 Titanium (cold-worked), a material clinically proven for more than 20 years. According to MegaGen, this ensures the biocompatibility of pure titanium implants while guaranteeing long-term biological survival rates. Through continuous research and development in implant design to enhance strength, BlueDiamond has achieved both high compressive and fatigue strength. As a result, it offers more than 200% greater strength compared to conventional implants, ensuring long-term mechanical stability.

Self-tapping design

BlueDiamond Implant’s unique KnifeThread and its self-tapping design features provide superior initial stability in any compromised bone condition. MegaGen stated, “With the option of different thread depths (regular or deep) on the same core diameter, the BlueDiamond implant ensures excellent primary stability and easy placement in any bone quality, while its design evenly distribute stress to the surrounding bone. The BlueDiamond Implant is treated with unique XPEED surface treatment technology. After the S-L-A process is applied to Grade 4 pure titanium, Ca2+ ions are incorporated onto the implant surface. This promotes faster and stronger osseointegration, delivering higher ISQ values and improved long-term safety. In addition, having been recognized with the “Clean Implant Trusted Quality Award” for nine consecutive years, the XPEED-treated BlueDiamond Implant exhibits its distinctive blue surface due to the complete removal of residual acids. Its consistent surface roughness (Ra) further ensures uniform bone growth.

Advanced implant system for the digital age

The BlueDiamond Implant is a premium solution optimized for the digital era, offering octa prosthetic positioning to enhance accuracy. The BlueDiamond Implant have a unique X-Fit connection with a 30° internal conical connection and double-fastened internal structure of an arch keystone and octa combination. MegaGen emphasized, “This robust and precise connection prevents prosthetic misfit and screw lossening, reducing unnecessary patient chair time.” The threadless design at the top of the implant helps maintain the biologically ideal facial bone thickness of over 2mm, preserving the cortical bone as much as possible.

Targeting zero fractures

Dental professionals who have used the BlueDiamond implant in clinical practice have given very positive feedback. One clinician commented, “I often worry about implant fractures during placement. For posterior, Ø4.5 implants could risk cracking, while Ø4.0 often raised concerns about subsequent GBR.” He added, “The BlueDiamond Implant, however, can be safely used in posterior regions with Ø4.1, in premolars with Ø3.7, and even in lower anterior or upper lateral incisors with Ø3.3, without any strength concerns. Its versatility makes it suitable for virtually any case.” He further noted, “With the increasing number of implant patients covered by insurance and elderly patients, we often encounter cases with poor bone quality. The BlueDiamond Implant allows us to place implants with sufficient strength while minimizing bone grafting, making it especially useful for patients with compromised bone. In addition, the aesthetic soft tissue response is superior to previous systems, which has been very satisfying.”

Safety, Convenience, and Accuracy – All in One

마케팅 — Thu, 23 Oct 2025 17:49:22 +0000

R2StudioQ Ensures Dental Treatments Go Exactly as Planned

MegaGen Implant Co., Ltd. (CEO KwangBum Park, hereinafter ‘MegaGen’) is drawing attention with its digital workstation, the R2StuidoQ, which has received positive feedbacks from users. Offering a clear solution with the promise of “Achieving predictable outcomes as planned,” the R2StuidoQ has evolved beyond simple CT scans into a full-fledged digital workstation.

Creating a digital patient in 10 minutes

The R2StudioQ enables the creation of a digital patient in just 10 minutes, allowing clinicians to establish highly accurate diagnoses and develop suitable treatment plans with minimal deviation from the actual patient. This facilitates close and informed consultations with patients. MegaGen emphasized, “The R2StudioQ has evolved from merely viewing CT scans to becoming a fully functional digital workstation.” The R2StudioQ can simultaneously capture CT, facial and impression scans with a single device. By merging this data, it creates a digital patient, enabling clinicians to plan treatment, consult with patients, and exchange information with the dental lab – ultimately producing the final results exactly as planned. MegaGen explained, “The biggest advantage is that the entire process, from transmitting the finalized treatment plan to the dental lab to achieving the desired outcome, can be done using a single device and software. This is especially valuable for full-arch aesthetic treatments, where predictable results and precise treatment execution according to plan are essential.

Treatment planning

The R2StudioQ enables the creation of an ideal smile line using Digital Oral Design (DOD). Clinicians can visually adjust the patient’s smile line while arranging a library of reference teeth designed with aesthetically harmonious proportions. By simultaneously evaluating the mid-facial line, smile line, and lateral jaw profile, the optimal tooth positions can be selected to achieve a balanced and naturally appealing smile. Using the arranged tooth library as a guide, the EZ Wax-up function lets clinicians create a wax-up on an ideal occlusal table. By comparing the current tooth positions with the planned ideal positions, they can choose the most appropriate treatment options. The system can capture images with a maximum field of view of 18 cm × 16 cm, making it versatile enough for small procedures like root canals, full-arch restorations, aesthetic treatments, or even large-area scans needed for orthodontics – adapting easily to each patient’s treatment plan. MegaGen stated, “The R2Studio Q not only enables the creation of personalized treatment plans for each patient but also supports the implementation of a true top-down treatment approach.”

Precise treatment planning with R2Gate

MegaGen’s R2Gate is a digital solution based on the top-down treatment concept. It overlays intraoral scan files onto CBCT images, loads the design files of the teeth to the restored, and determines the optimal implant position based on the final prosthesis. The system enables guided surgery, allowing clinicians to place implants precisely according to the planned position and significantly enhancing treatment accuracy. Additionally, MegaGen has introduced a solution that allows for the placement of temporary prosthesis within just 10 minutes, significantly reducing patient’s chair time. This system enhances both convenience and precision throughout the treatment process, drawing attention from clinicians worldwide. The R2 Chairside Solution comprises an intraoral scanner, planning software (R2Gate), dental CAD software (R2CAD), a milling unit (BX5), and a 3D printer (Meg Printer 2Q). This integrated system allows dental clinics to handle even simple restorations in-house, eliminating the need to send prosthetics to an external dental lab. Using the i700(i600) intraoral scanner, the R2 Chairside Solution quickly and accurately captures the patient’s oral data. This information is then optimized through R2Gate and sent to the BX5 milling machine, enabling the fabrication of temporary restorations within just 10 minutes. This has allowed patients to receive their temporary prosthesis on the same day as the implant treatment. MegaGen highlighted, “The system allows in-house fabrication without the need for an external dental lab, enabling same-day production using only the existing clinic staff. This makes it possible to transition to a fully digital workflow without additional personnel. It also allows restorations to be fabricated while the patient is seated, significantly reducing chair time.” In particular, the PMMA Abutment, a cementless implant prosthesis that can be milled in under 10 minutes, is especially convenient when paired with a scan healing abutment. A single healing attachment allows for easy scanning, ensures a pain-free fit with its consistent cuff design, and helps preserve healthy gum around the implant. For additional information, including product inquiries, please visit MegaGen’s official website.

AI-Powered R2i3 Gains Attention with Fast and Precise Scanning

마케팅 — Thu, 23 Oct 2025 17:46:47 +0000

Enhancing User Convenience and Reliability with R2 Cloud Sharing

MegaGen Implant Co., Ltd. (CEO KwangBum Park, hereinafter ‘MegaGen’) has introduced the innovative oral scanner R2i3, which has received strong positive feedback for its differentiated and compelling concept. MegaGen stated, “The R2i3 not only expands the use of scanner in dentistry with AI-powered consultation features, but is also recognized as a cost-effective solution that combines outstanding performance, high precision, and simple operation.” MegaGen explained that many clinics are adopting the R2i3, encouraged by positive word-of-mouth from various clinics. They have experienced smoother consultations and communication with patients through its dedicated software and cloud system, which enable real-time oral scanning and immediate consultation.

A precise digital workflow with real-time consultation

The R2i3 goes beyond traditional impressions as it utilizes AI technology to deliver highly precise analysis of patients’ teeth, which results that can be reviewed instantly. It is positioned as an innovative oral scanner that facilitates smoother communication between dentists and patients while strengthening patient trust in dental care. It’s especially useful during patient consultations, helping patients quickly understand their current dental condition and allowing dentists to easily plan the necessary treatment. This not only makes consultations more effective but also helps the clinic stand out. The R2i3, connected with the CHI-TOK software, enables real-time consultations with patients. Its built-in AI automatically detects dental issues and presents them visually, making it easier for patients to understand their condition and helping to build trust. Additionally, the R2 Cloud Sharing feature lets consultation results be sent directly to patients’ mobile devices in an easy-to-read report, helping increase understanding and consent from both patients and clinicians. MegaGen added, “This improves patients’ understanding of their treatment, fostering trust, and also plays a key role in creating personalized treatment plans while efficiently addressing patients’ needs.”

Maximizing user-friendliness and efficiency

The R2i3 features a user-friendly interface that allows dentists and their staff to get up to speed quickly. Thanks to its AI-powered technology, it scans about 30% faster than comparable devices, helping to shorten treatment time and improve overall workflow efficiency. The R2i3’s AI function automatically defects and excludes unnecessary scanning areas, such as soft tissues, the tongue, and cheeks. This reduces scanning time and provides a more convenient, user-friendly scanning experience. The scanning process is simplified so that full maxillary, mandibular, and occlusal scans can be completed with a single button without any mouse operation. This streamlined workflow shortens treatment time, allowing clinics to manage more patients with reduced waiting. The R2i3’s metal scanning capability also stands out. Traditionally, scanning metal prostheses required applying a spray to minimize light reflection. However, the R2i3 makes it easier to scan patients with metal crowns, bridges, inlays and amalgam fillings to obtain accurate intraoral data. This significantly reduces scanning time and provides a more comfortable experience for both patients and clinicians. It is advantageous not only for implant cases but also across a wide range of restorative and orthodontic treatments. The R2i3 was officially launched at SIDEX 2024 in South Korea. Just four month after its release, 400 nits have been sold, and it continues to receive strong demands from dental clinics nationwide.. MegaGen stated, “The installation schedule is currently fully booked through October 2024. Even if an order is placed now, installation can only take place by the end of October. We plan to allocate additional installation teams to meet this growing demand.” They added, “For clinics that are still hesitant to adopt an intraoral scanner or find patient consultations challenging, we strongly recommend the R2i3.” For additional information, including product inquiries, please visit MegaGen’s official website.

First Class Care for Patients, First Class Performance for Clinicians

마케팅 — Thu, 23 Oct 2025 17:43:23 +0000

The First Class, N3: Creating a New Standard in Treatment Environment

MegaGen Implant Co., Ltd. (CEO KwangBum Park, hereinafter ‘MegaGen’) has introduced its high-end unit chair, the N3, which combines elegant design with premium functionality. Equipped with a wide range of features that rival any leading chair on the global market, the N3 stands out for its superior treatment convenience and hygiene management.

Reflecting the needs of dental practitioners

The N3 was developed by incorporating years of clinical experience and insights from dental professionals, resulting in a unit chair fully optimized for an ideal treatment environment. MegaGen stated that the N3 features premium upholstery typically used in automobiles. In addition, for the first time in the world, it incorporates built-in ventilation and heating functions. This allows patients to experience maximum comfort during long treatments or surgical procedures. Furthermore, for practitioners who prefer standing treatment, the seat height can be raised up to 850mm, among the highest levels of conventional unit chairs. The backrest is also slimmer than previous models, significantly reducing the interference and allowing easy access from any angle. One of the N3’s technologies is its real-time hot water supply function. To minimize patient discomfort from cold water during treatment, the N3 delivers hot water in real time to all instruments, from syringes to scalers, and maintains the water temperature throughout the procedure. Hygiene is enhanced by supplying all water in real time with 99.9% UV sterilization, and this technology is semi-permanent, minimizing the need for component replacement.

Equipped with advanced convenience features for a practical upgrade

The N3 comes with individual(separated) selective suction valve that integrate a backflow prevention system and an automatic suction filter cleaning function, ensuring both effective infection control and odor elimination. Also, the widely recognized hands-free 2^nd assistant function from the previous N2 model now comes as a standard feature, further enhancing clinical efficiency. In the event of a power outage, the N3 automatically shuts off the water and air lines to prevent leakage risks. It also offers premium patient-friendly features such as wireless smartphone charging, a glasses holder, and a built-in trash bin. The dental light adopts the largest reflector among dental lights in Korea, maximizing shadowless performance. It also offers adjustable color temperature to suit different treatment needs, along with a wide light distribution pattern. Auxiliary LEDs have been applied to illuminate areas around the oral cavity where shadowless effect is often limited, ensuring an optimal treatment environment. In addition, a full touchscreen controller allows for more intuitive operation. MegaGen stated, “The first class unit chair N3 was developed with a strong focus on clinician convenience, incorporating a wide range of features that reflect the real needs of practitioners. At the same time, we paid close attention to even the smallest details to ensure patients experience greater comfort during treatment, raising the standard of product excellence.” For additional information, including product inquiries, please visit MegaGen’s official website.